1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, November 2016 (p4)

Biological Therapy Analysis & Statistics, November 2016 (p4)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

91-120 of about 1000 reports

Purchase Reports From Reputable Market Research Publishers

2016-2021  US Cell Surface Marker Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

2016-2021 US Cell Surface Marker Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 1450
  • Industry report
  • November 2016
  • by Venture Planning Group

Complete report $2,050.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
Report Package: Hot targets for empowered antibody and cell therapy technologies

Report Package: Hot targets for empowered antibody and cell therapy technologies

  • $ 1254
  • Industry report
  • December 2016
  • by La Merie Publishing

Report Package: Hot targets for empowered antibody and cell therapy technologies This package contains three reports analyzing BCMA, CD123 and CD22 as versatile and hot targets for the successful ...

  • Industries : Biological Therapy
Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2017

Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast activation protein (FAP) antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : Biological Therapy
Anti GM-CSF Antibody -Pipeline Insights, 2017

Anti GM-CSF Antibody -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Anti GM-CSF Antibody-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anti GM-CSF Antibody. The DelveInsight’s ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor (FGFR) Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2017

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hematopoietic ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation
Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2017

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development ...

  • Industries : Biological Therapy
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast ...

  • Industries : Biological Therapy
Growth Hormone Antagonists -Pipeline Insights, 2017

Growth Hormone Antagonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Growth Hormone Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Antagonists. ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Interleukin (IL) Inhibitors -Pipeline Insights, 2017

Interleukin (IL) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Interleukin (IL) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin (IL) Inhibitors. ...

  • Industries : Biological Therapy
CD8+ T cell Activators -Pipeline Insights, 2017

CD8+ T cell Activators -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “CD8+ T cell Activators-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the CD8+ T cell Activators. The ...

  • Industries : Biological Therapy
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2017

Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development ...

  • Industries : Biological Therapy
Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2017

Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Broad Spectrum Chemokine Inhibitors (BSCIs)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Broad Spectrum ...

  • Industries : Biological Therapy
Growth Hormone (GH) Agonists -Pipeline Insights, 2017

Growth Hormone (GH) Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Growth Hormone (GH) Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone (GH) Agonists. ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2017

Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Interferon Gamma Receptor (IFNGR) Binders-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Interferon ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
G-CSF Inhibitors -Pipeline Insights, 2017

G-CSF Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “G-CSF Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the G-CSF Inhibitors. The DelveInsight’s ...

  • Industries : Biological Therapy
Interferon Receptor Binders -Pipeline Insights, 2017

Interferon Receptor Binders -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Interferon Receptor Binders-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Interferon Receptor Binders. ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2017

GM-CSF Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “GM-CSF Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the GM-CSF Inhibitors. The DelveInsight’s ...

  • Industries : Biological Therapy
T Cell Inhibitors -Pipeline Insights, 2017

T Cell Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “T Cell Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the T Cell Inhibitors. The DelveInsight’s ...

  • Industries : Biological Therapy
Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2017

Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Hepatocyte growth factor (HGF) mimetic-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatocyte growth ...

  • Industries : Biological Therapy
 Growth Hormone Deficiency-Pipeline Insights, 2017

Growth Hormone Deficiency-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Growth Hormone Deficiency-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Deficiency. ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2017

Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Growth Factor (FGF) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast ...

  • Industries : Biological Therapy
B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2017

B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “B-Cell Activating Factor (BAFF) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Activating ...

  • Industries : Biological Therapy
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2017

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
About 4000 reports

Download Unlimited Documents from Trusted Public Sources

Cytokine Industry in the US

  • February 2017
    11 pages
  • Cytokine  

  • United States  

View report >

Cytokine Supply

February 2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.